As the pharma industry makes the transition for the world to move from ‘illness to wellness’ Umang Vohra, Global CEO & MD of Cipla says innovation not generics will be the next big bet for the sector.
In an exclusive chat with Editorji and Fortune India Cipla's Global CEO & MD says he expects to see over 70% of Indians vaccinated by June 2022 and is confident that Covid will become just another flu the world will learn to live with.
On the question of boosters, the Cipla chief says the current dose of boosters are not ’true boosters’ and are largely just an extra shot as the virus continues to mutate.